Nicholas Investment Partners, LP Illumina, Inc. Transaction History

Nicholas Investment Partners, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$288.29 - $335.49 $4.93 Million - $5.74 Million	-17,103 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$266.84 - $378.23 $871,232 - $1.23 Million	3,265 Added 23.59%	17,103 $5.2 Million
Q2 2019 Aug 09, 2019	SELL	$300.59 - $368.15 $234,460 - $287,157	-780 Reduced 5.34%	13,838 $5.09 Million
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $3.51 Million - $4.13 Million	-12,865 Reduced 46.81%	14,618 $4.54 Million
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $1.13 Million - $1.52 Million	-4,140 Reduced 13.09%	27,483 $8.24 Million
Q3 2018 Nov 14, 2018	SELL	$279.04 - $367.06 $445,068 - $585,460	-1,595 Reduced 4.8%	31,623 $11.6 Million
Q2 2018 Aug 14, 2018	BUY	$228.17 - $292.07 $330,161 - $422,625	1,447 Added 4.55%	33,218 $9.28 Million
Q1 2018 May 15, 2018	BUY	$209.54 - $253.91 $6.66 Million - $8.07 Million	31,771 New	31,771 $7.51 Million

899

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.